Title:
RNA-based Drugs for Treating Influenza and SARS-CoV-2

Thumbnail Image
Author(s)
Santangelo, Philip J.
Authors
Advisor(s)
Advisor(s)
Editor(s)
Associated Organization(s)
Series
Collections
Supplementary to
Abstract
RNA-based drugs for treating influenza and SARS-CoV-2 will be discussed. In particular, I’ll talk about why we make drugs based on synthetic mRNA and why RNA based drugs make sense for treating infections. In addition, I’ll discuss how my lab has been using mRNA-based Cas13 to target and mitigate influenza virus A (IAV) and SARS-CoV-2. I’ll discuss how we have made strides towards a pan-influenza treatment and show significant mitigation of SARS-CoV-2 in vitro. Last, I’ll talk about how we administer these drugs in vivo and preliminary data demonstrating function.
Sponsor
Date Issued
2020-05-06
Extent
55:16 minutes
Resource Type
Moving Image
Resource Subtype
Lecture
Rights Statement
Rights URI